BioCentury | Jul 19, 2018
Translation in Brief

Public Funding Highlights: 2Q18

...Projects competition to bridge artificial intelligence and health research Grants June 15 Scottish Enterprise , UKRI Scottish Enterprise...
BioCentury | Jun 27, 2016
Financial News

Mironid completes venture financing

...Cancer Date completed: 2016-06-20 Type: Venture financing Raised: L4.3 million ($6.3 million) Investors: Epidarex Capital; Scottish Enterprise...
BioCentury | May 19, 2016
Finance

Found in translation

...2014 Epidarex Epidarex Capital; Eli Lilly and Co. (NYSE:LLY); King's College London; European Investment Fund; Scottish Enterprise...
BioCentury | Mar 23, 2015
Company News

Synpromics, uniQure deal

...virus (AAV)-based gene therapies to the liver. The partnership is supported by a grant from Scottish Enterprise’s...
BioCentury | Sep 22, 2014
Financial News

MGB Biopharma completes venture financing

...financing Raised: L2.7 million ($4.4 million) Investors: Archangel Informal Investment; Barwell plc; Tri Capital Ltd.; Scottish Enterprise WIR...
BioCentury | Jun 2, 2014
Financial News

Epidarex Capital Partners LLC financial update

...Lilly and Co. (NYSE:LLY, Indianapolis, Ind.); King's College London ; the European Investment Fund (EIF); Scottish Enterprise...
BioCentury | May 29, 2014
Financial News

Epidarex raises L47.5 million for first fund

...included Eli Lilly and Co. (NYSE:LLY); King's College London ; the European Investment Fund (EIF); Scottish Enterprise...
BioCentury | Mar 17, 2014
Company News

Medinet, TC Biopharm deal

...could not be reached for details. TC Biopharm also received a £500,000 ($835,400) award from Scottish Enterprise...
BioCentury | Sep 23, 2013
Financial News

Ubiquigent completes venture financing

...Gene/Cell therapy, Supply/Service Date completed: 9/18/13 Type: Venture financing Raised: £500,000 ($797,100) Investors: IP Group; Scottish Enterprise WIR...
BioCentury | Mar 3, 2011
Strategy

Scots aggregate a ligase platform

...For the past three years, Scottish Enterprise has been working with multiple international academic and commercial labs...
...open question has been whether selective ligase-targeting compounds can be identified or designed. In 2008, Scottish Enterprise...
...which was acquired by Merck KGaA in 2010. Funding for the program came from Scottish Enterprise's...
Items per page:
1 - 10 of 21
BioCentury | Jul 19, 2018
Translation in Brief

Public Funding Highlights: 2Q18

...Projects competition to bridge artificial intelligence and health research Grants June 15 Scottish Enterprise , UKRI Scottish Enterprise...
BioCentury | Jun 27, 2016
Financial News

Mironid completes venture financing

...Cancer Date completed: 2016-06-20 Type: Venture financing Raised: L4.3 million ($6.3 million) Investors: Epidarex Capital; Scottish Enterprise...
BioCentury | May 19, 2016
Finance

Found in translation

...2014 Epidarex Epidarex Capital; Eli Lilly and Co. (NYSE:LLY); King's College London; European Investment Fund; Scottish Enterprise...
BioCentury | Mar 23, 2015
Company News

Synpromics, uniQure deal

...virus (AAV)-based gene therapies to the liver. The partnership is supported by a grant from Scottish Enterprise’s...
BioCentury | Sep 22, 2014
Financial News

MGB Biopharma completes venture financing

...financing Raised: L2.7 million ($4.4 million) Investors: Archangel Informal Investment; Barwell plc; Tri Capital Ltd.; Scottish Enterprise WIR...
BioCentury | Jun 2, 2014
Financial News

Epidarex Capital Partners LLC financial update

...Lilly and Co. (NYSE:LLY, Indianapolis, Ind.); King's College London ; the European Investment Fund (EIF); Scottish Enterprise...
BioCentury | May 29, 2014
Financial News

Epidarex raises L47.5 million for first fund

...included Eli Lilly and Co. (NYSE:LLY); King's College London ; the European Investment Fund (EIF); Scottish Enterprise...
BioCentury | Mar 17, 2014
Company News

Medinet, TC Biopharm deal

...could not be reached for details. TC Biopharm also received a £500,000 ($835,400) award from Scottish Enterprise...
BioCentury | Sep 23, 2013
Financial News

Ubiquigent completes venture financing

...Gene/Cell therapy, Supply/Service Date completed: 9/18/13 Type: Venture financing Raised: £500,000 ($797,100) Investors: IP Group; Scottish Enterprise WIR...
BioCentury | Mar 3, 2011
Strategy

Scots aggregate a ligase platform

...For the past three years, Scottish Enterprise has been working with multiple international academic and commercial labs...
...open question has been whether selective ligase-targeting compounds can be identified or designed. In 2008, Scottish Enterprise...
...which was acquired by Merck KGaA in 2010. Funding for the program came from Scottish Enterprise's...
Items per page:
1 - 10 of 21